Schonfeld Strategic Advisors LLC Cue Biopharma, Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.24 - $2.18 $29,760 - $52,320	24,000 New	24,000 $29,000
Q3 2022 Nov 14, 2022	SELL	$2.23 - $3.37 $99,373 - $150,173	-44,562 Reduced 74.69%	15,100 $34,000
Q2 2022 Aug 15, 2022	BUY	$2.49 - $5.92 $52,693 - $125,279	21,162 Added 54.97%	59,662 $149,000
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $40,620 - $113,111	-9,211 Reduced 19.31%	38,500 $188,000
Q4 2021 Feb 14, 2022	BUY	$10.86 - $17.85 $518,141 - $851,641	47,711 New	47,711 $540,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.